- Home
- FGBI vs TARA Comparison
FGBI vs TARA Comparison
Compare FGBI & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGBI
- TARA
- Stock Information
- Founded
- FGBI 1934
- TARA N/A
- Country
- FGBI United States
- TARA United States
- Employees
- FGBI N/A
- TARA N/A
- Industry
- FGBI Savings Institutions
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FGBI Finance
- TARA Health Care
- Exchange
- FGBI Nasdaq
- TARA Nasdaq
- Market Cap
- FGBI 122.8M
- TARA 118.1M
- IPO Year
- FGBI N/A
- TARA N/A
- Fundamental
- Price
- FGBI $8.93
- TARA $4.86
- Analyst Decision
- FGBI
- TARA Strong Buy
- Analyst Count
- FGBI 0
- TARA 6
- Target Price
- FGBI N/A
- TARA $19.80
- AVG Volume (30 Days)
- FGBI 7.8K
- TARA 723.1K
- Earning Date
- FGBI 10-30-2025
- TARA 11-11-2025
- Dividend Yield
- FGBI 0.45%
- TARA N/A
- EPS Growth
- FGBI N/A
- TARA N/A
- EPS
- FGBI N/A
- TARA N/A
- Revenue
- FGBI $59,070,000.00
- TARA N/A
- Revenue This Year
- FGBI N/A
- TARA N/A
- Revenue Next Year
- FGBI $0.20
- TARA N/A
- P/E Ratio
- FGBI N/A
- TARA N/A
- Revenue Growth
- FGBI N/A
- TARA N/A
- 52 Week Low
- FGBI $6.56
- TARA $1.60
- 52 Week High
- FGBI $15.25
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- FGBI 67.11
- TARA 75.10
- Support Level
- FGBI $7.85
- TARA $4.10
- Resistance Level
- FGBI $8.25
- TARA $5.03
- Average True Range (ATR)
- FGBI 0.15
- TARA 0.35
- MACD
- FGBI 0.09
- TARA 0.11
- Stochastic Oscillator
- FGBI 93.91
- TARA 88.04
About FGBI First Guaranty Bancshares Inc.
First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).